$FLXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Flexion Therapeutics Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Flexion Therapeutics Inc. Get notifications about new insider transactions in Flexion Therapeutics Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 09 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | M | 0.00 | 14,800 | 0 | 14,800 | |
Oct 09 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Payment of Exercise | F | 18.60 | 6,233 | 115,934 | 83,849 | 90.1 K to 83.8 K (-6.92 %) |
Oct 09 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | M | 0.00 | 14,800 | 0 | 90,082 | 75.3 K to 90.1 K (+19.66 %) |
Oct 09 2018 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Payment of Exercise | F | 18.60 | 1,002 | 18,637 | 11,476 | 12.5 K to 11.5 K (-8.03 %) |
Aug 10 2018 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Buy | P | 23.42 | 4,000 | 93,680 | 44,250 | 40.3 K to 44.3 K (+9.94 %) |
Aug 10 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 22.33 | 10,000 | 223,300 | 75,282 | 65.3 K to 75.3 K (+15.32 %) |
Jun 22 2018 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Buy | J | 21.22 | 171 | 3,629 | 12,478 | 12.3 K to 12.5 K (+1.39 %) |
Jun 22 2018 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Buy | J | 21.22 | 1,001 | 21,241 | 15,893 | 14.9 K to 15.9 K (+6.72 %) |
Jun 22 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | J | 21.22 | 554 | 11,756 | 65,282 | 64.7 K to 65.3 K (+0.86 %) |
Jun 22 2018 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Buy | J | 21.22 | 539 | 11,438 | 8,872 | 8.3 K to 8.9 K (+6.47 %) |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Option Exercise | A | 28.14 | 12,500 | 351,750 | 12,500 | |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | A | 28.14 | 12,500 | 351,750 | 12,500 | |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 28.14 | 12,500 | 351,750 | 12,500 | |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Option Exercise | A | 28.14 | 12,500 | 351,750 | 12,500 | |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 28.14 | 12,500 | 351,750 | 12,500 | |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 28.14 | 12,500 | 351,750 | 12,500 | |
Jun 21 2018 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 28.14 | 18,000 | 506,520 | 18,000 | |
Jun 04 2018 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Option Exercise | A | 27.01 | 115,000 | 3,106,150 | 115,000 | |
Jun 04 2018 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 40,250 | 10.3 K to 40.3 K (+292.68 %) |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Option Exercise | A | 22.31 | 33,333 | 743,659 | 33,333 | |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Grant | A | 0.00 | 8,333 | 0 | 12,307 | 4 K to 12.3 K (+209.69 %) |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Option Exercise | A | 22.31 | 33,333 | 743,659 | 33,333 | |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | A | 22.31 | 116,667 | 2,602,841 | 116,667 | |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Grant | A | 0.00 | 29,167 | 0 | 64,728 | 35.6 K to 64.7 K (+82.02 %) |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Option Exercise | A | 22.31 | 40,000 | 892,400 | 40,000 | |
Feb 02 2018 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 74,605 | 64.6 K to 74.6 K (+15.48 %) |
Dec 22 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | J | 16.59 | 166 | 2,754 | 35,561 | 35.4 K to 35.6 K (+0.47 %) |
Dec 22 2017 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Buy | J | 16.59 | 858 | 14,234 | 6,559 | 5.7 K to 6.6 K (+15.05 %) |
Nov 22 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Buy | P | 24.66 | 1,000 | 24,656 | 1,000 | 0 to 1,000 |
Nov 22 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Buy | P | 24.39 | 1,700 | 41,457 | 64,605 | 62.9 K to 64.6 K (+2.70 %) |
Nov 09 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 23.60 | 5,000 | 118,000 | 35,395 | 30.4 K to 35.4 K (+16.45 %) |
Oct 10 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Option Exercise | M | 0.00 | 4,566 | 0 | 9,134 | |
Oct 10 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Payment of Exercise | F | 29.93 | 1,598 | 47,835 | 62,905 | 64.5 K to 62.9 K (-2.48 %) |
Oct 10 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Buy | M | 0.00 | 4,566 | 0 | 64,503 | 59.9 K to 64.5 K (+7.62 %) |
Oct 10 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | M | 0.00 | 14,800 | 0 | 29,600 | |
Oct 10 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Payment of Exercise | F | 29.93 | 5,794 | 173,443 | 30,395 | 36.2 K to 30.4 K (-16.01 %) |
Oct 10 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | M | 0.00 | 14,800 | 0 | 36,189 | 21.4 K to 36.2 K (+69.19 %) |
Sep 15 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Option Exercise | P | 22.50 | 10 | 225 | 10 | |
Sep 15 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Option Exercise | P | 30.00 | 20 | 600 | 20 | |
Sep 15 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Buy | P | 24.20 | 1,000 | 24,200 | 9,000 | 8 K to 9 K (+12.50 %) |
Sep 15 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Buy | P | 23.95 | 2,000 | 47,900 | 8,000 | 6 K to 8 K (+33.33 %) |
Sep 15 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Buy | P | 24.55 | 1,000 | 24,550 | 6,000 | 5 K to 6 K (+20.00 %) |
Sep 15 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Buy | P | 25.40 | 1,375 | 34,925 | 5,000 | 3.6 K to 5 K (+37.93 %) |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | Lukatch Heath | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 20.16 | 12,500 | 252,000 | 12,500 | |
Jul 27 2017 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 20.16 | 18,000 | 362,880 | 18,000 | |
Jun 26 2017 | FLXN | Flexion Therapeuti ... | Levine Mark S. | SVP & General Couns ... | Option Exercise | A | 21.74 | 125,000 | 2,717,500 | 125,000 | |
Jun 23 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | J | 15.37 | 1,243 | 19,105 | 21,389 | 20.1 K to 21.4 K (+6.17 %) |
Jun 20 2017 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Buy | P | 17.02 | 1,580 | 26,888 | 1,580 | 0 to 1.6 K |
Jun 06 2017 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 17.01 | 5,000 | 85,048 | 5,000 | 0 to 5 K |
Jun 06 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 17.23 | 5,000 | 86,152 | 20,146 | 15.1 K to 20.1 K (+33.01 %) |
Apr 18 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 28.86 | 200 | 5,772 | 45,937 | 46.1 K to 45.9 K (-0.43 %) |
Apr 18 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 28.20 | 4,800 | 135,360 | 46,137 | 50.9 K to 46.1 K (-9.42 %) |
Apr 05 2017 | FLXN | Flexion Therapeuti ... | Deniz Yamo | Chief Medical Offic ... | Option Exercise | A | 27.43 | 150,000 | 4,114,500 | 150,000 | |
Mar 24 2017 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Option Exercise | M | 7.89 | 3,000 | 23,658 | 102,300 | |
Mar 24 2017 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Sell | S | 23.00 | 3,000 | 69,000 | 7,777 | 10.8 K to 7.8 K (-27.84 %) |
Mar 24 2017 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | M | 7.89 | 3,000 | 23,658 | 10,777 | 7.8 K to 10.8 K (+38.58 %) |
Mar 20 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 20.41 | 5,000 | 102,039 | 50,937 | 55.9 K to 50.9 K (-8.94 %) |
Mar 10 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 15,722 | 0 | 294,383 | 278.7 K to 294.4 K (+5.64 %) |
Mar 10 2017 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 15,722 | 0 | 15,146 | 30.9 K to 15.1 K (-50.93 %) |
Feb 27 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 19.15 | 5,000 | 95,758 | 55,937 | 60.9 K to 55.9 K (-8.21 %) |
Jan 23 2017 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 18.35 | 5,000 | 91,747 | 60,937 | 65.9 K to 60.9 K (-7.58 %) |
Dec 27 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | J | 9.01 | 1,134 | 10,217 | 10,531 | 9.4 K to 10.5 K (+12.07 %) |
Dec 27 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | J | 9.01 | 147 | 1,324 | 30,868 | 30.7 K to 30.9 K (+0.48 %) |
Dec 22 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 18.46 | 10,000 | 184,628 | 65,937 | 75.9 K to 65.9 K (-13.17 %) |
Dec 22 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Option Exercise | A | 18.56 | 50,000 | 928,000 | 50,000 | |
Dec 22 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | A | 18.56 | 175,000 | 3,248,000 | 175,000 | |
Dec 22 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Option Exercise | A | 18.56 | 65,000 | 1,206,400 | 65,000 | |
Dec 05 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 16.38 | 10,000 | 163,807 | 43,333 | 33.3 K to 43.3 K (+30.00 %) |
Nov 23 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 18.41 | 1,667 | 30,688 | 30,721 | 29.1 K to 30.7 K (+5.74 %) |
Nov 23 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 17.95 | 1,666 | 29,900 | 29,054 | 27.4 K to 29.1 K (+6.08 %) |
Nov 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 18.00 | 33,333 | 599,994 | 33,333 | 0 to 33.3 K |
Nov 22 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 17.90 | 1,666 | 29,827 | 27,388 | 25.7 K to 27.4 K (+6.48 %) |
Sep 14 2016 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Option Exercise | A | 15.87 | 25,000 | 396,750 | 25,000 | |
Jun 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.71 | 400 | 5,483 | 25,504 | 25.1 K to 25.5 K (+1.59 %) |
Jun 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.65 | 504 | 6,881 | 25,104 | 24.6 K to 25.1 K (+2.05 %) |
Jun 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.76 | 4,600 | 63,288 | 24,600 | 20 K to 24.6 K (+23.00 %) |
Jun 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.62 | 13,222 | 180,114 | 20,000 | 6.8 K to 20 K (+195.07 %) |
Jun 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.70 | 3,343 | 45,813 | 6,778 | 3.4 K to 6.8 K (+97.32 %) |
Jun 22 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.98 | 3,435 | 48,020 | 3,435 | 0 to 3.4 K |
Jun 16 2016 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Buy | P | 13.39 | 1,000 | 13,387 | 2,000 | 1,000 to 2 K (+100.00 %) |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | A | 13.83 | 12,500 | 172,875 | 12,500 | |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 13.83 | 12,500 | 172,875 | 12,500 | |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Option Exercise | A | 13.83 | 12,500 | 172,875 | 12,500 | |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 13.83 | 18,000 | 248,940 | 18,000 | |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | Lukatch Heath | Director | Option Exercise | A | 13.83 | 12,500 | 172,875 | 12,500 | |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 13.83 | 12,500 | 172,875 | 12,500 | |
Jun 13 2016 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 13.83 | 12,500 | 172,875 | 12,500 | |
Jun 10 2016 | FLXN | Flexion Therapeuti ... | LUBASH BARBARA N | 10% Owner | Buy | P | 14.00 | 4,194 | 58,716 | 20,739 | 16.5 K to 20.7 K (+25.35 %) |
Jun 10 2016 | FLXN | Flexion Therapeuti ... | LUBASH BARBARA N | 10% Owner | Buy | P | 14.00 | 710,091 | 9,941,274 | 3,511,670 | 2.8 M to 3.5 M (+25.35 %) |
Jun 10 2016 | FLXN | Flexion Therapeuti ... | Versant Ventures III, LLC | 10% Owner | Buy | P | 14.00 | 4,194 | 58,716 | 20,739 | 16.5 K to 20.7 K (+25.35 %) |
Jun 10 2016 | FLXN | Flexion Therapeuti ... | Versant Ventures III, LLC | 10% Owner | Buy | P | 14.00 | 710,091 | 9,941,274 | 3,511,670 | 2.8 M to 3.5 M (+25.35 %) |
Jun 10 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 14.00 | 4,194 | 58,716 | 20,739 | 16.5 K to 20.7 K (+25.35 %) |
Jun 10 2016 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 14.00 | 710,091 | 9,941,274 | 3,511,670 | 2.8 M to 3.5 M (+25.35 %) |
May 24 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | M | 0.16 | 10,369 | 1,686 | 0 | |
May 24 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | M | 0.16 | 10,369 | 1,686 | 25,722 | 15.4 K to 25.7 K (+67.54 %) |
May 24 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | J | 8.92 | 963 | 8,590 | 9,397 | 8.4 K to 9.4 K (+11.42 %) |
May 23 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 10.41 | 2,000 | 20,810 | 13,568 | 11.6 K to 13.6 K (+17.29 %) |
May 20 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 9.65 | 2,000 | 19,297 | 11,568 | 9.6 K to 11.6 K (+20.90 %) |
May 20 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Buy | P | 10.00 | 850 | 8,500 | 75,937 | 75.1 K to 75.9 K (+1.13 %) |
May 19 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 10.23 | 2,000 | 20,465 | 9,568 | 7.6 K to 9.6 K (+26.43 %) |
May 19 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Buy | P | 10.20 | 2,100 | 21,420 | 75,087 | 73 K to 75.1 K (+2.88 %) |
May 18 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | P | 9.87 | 2,500 | 24,668 | 8,434 | 5.9 K to 8.4 K (+42.13 %) |
May 18 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 9.73 | 2,000 | 19,465 | 7,568 | 5.6 K to 7.6 K (+35.92 %) |
May 18 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Buy | P | 9.60 | 800 | 7,680 | 72,987 | 72.2 K to 73 K (+1.11 %) |
May 17 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | P | 9.19 | 2,500 | 22,972 | 5,934 | 3.4 K to 5.9 K (+72.80 %) |
May 17 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 9.51 | 2,000 | 19,025 | 5,568 | 3.6 K to 5.6 K (+56.05 %) |
May 17 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Buy | P | 9.70 | 250 | 2,425 | 72,187 | 71.9 K to 72.2 K (+0.35 %) |
May 17 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Buy | P | 9.10 | 1,000 | 9,100 | 71,937 | 70.9 K to 71.9 K (+1.41 %) |
Jan 06 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | A | 0.00 | 66,600 | 0 | 66,600 | |
Jan 06 2016 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | A | 18.20 | 155,000 | 2,821,000 | 155,000 | |
Jan 06 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,650 | 0 | 25,650 | |
Jan 06 2016 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Option Exercise | A | 18.20 | 40,000 | 728,000 | 40,000 | |
Jan 06 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Option Exercise | A | 0.00 | 20,550 | 0 | 20,550 | |
Jan 06 2016 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Option Exercise | A | 18.20 | 55,000 | 1,001,000 | 55,000 | |
Sep 14 2015 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Buy | P | 23.00 | 1,000 | 23,000 | 1,000 | 0 to 1,000 |
Jun 22 2015 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Sell | S | 20.55 | 63,412 | 1,302,844 | 2,133,131 | 2.2 M to 2.1 M (-2.89 %) |
Jun 22 2015 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Sell | S | 20.07 | 50,888 | 1,021,225 | 2,196,543 | 2.2 M to 2.2 M (-2.26 %) |
Jun 22 2015 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Sell | S | 21.51 | 35,700 | 767,903 | 2,247,431 | 2.3 M to 2.2 M (-1.56 %) |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | A | 21.85 | 9,000 | 196,650 | 9,000 | |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 21.85 | 9,000 | 196,650 | 9,000 | |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Option Exercise | A | 21.85 | 9,000 | 196,650 | 9,000 | |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | Lukatch Heath | Director | Option Exercise | A | 21.85 | 9,000 | 196,650 | 9,000 | |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 21.85 | 9,000 | 196,650 | 9,000 | |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 21.85 | 9,000 | 196,650 | 9,000 | |
Jun 19 2015 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 21.85 | 18,000 | 393,300 | 18,000 | |
May 27 2015 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | J | 11.91 | 1,311 | 15,614 | 2,754 | 1.4 K to 2.8 K (+90.85 %) |
May 27 2015 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | J | 11.91 | 1,784 | 21,247 | 282,229 | 280.4 K to 282.2 K (+0.64 %) |
Mar 25 2015 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | M | 0.16 | 5,000 | 813 | 10,369 | |
Mar 25 2015 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | M | 0.16 | 5,000 | 813 | 280,445 | 275.4 K to 280.4 K (+1.82 %) |
Mar 16 2015 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 25.76 | 1,500 | 38,640 | 70,937 | 72.4 K to 70.9 K (-2.07 %) |
Mar 16 2015 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 24.99 | 2,500 | 62,475 | 72,437 | 74.9 K to 72.4 K (-3.34 %) |
Mar 11 2015 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 24.26 | 4,000 | 97,055 | 74,937 | 78.9 K to 74.9 K (-5.07 %) |
Mar 06 2015 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 25.38 | 18,000 | 456,840 | 18,000 | |
Mar 05 2015 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 23.45 | 4,000 | 93,790 | 78,937 | 82.9 K to 78.9 K (-4.82 %) |
Feb 26 2015 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Sell | S | 22.44 | 4,000 | 89,766 | 82,937 | 86.9 K to 82.9 K (-4.60 %) |
Jan 23 2015 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Option Exercise | A | 22.91 | 40,000 | 916,400 | 40,000 | |
Jan 23 2015 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | A | 22.91 | 110,000 | 2,520,100 | 110,000 | |
Jan 23 2015 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Option Exercise | A | 22.91 | 45,000 | 1,030,950 | 45,000 | |
Jan 22 2015 | FLXN | Flexion Therapeuti ... | Sofinnova Partners SAS | 10% Owner | Sell | S | 20.00 | 10,000 | 200,000 | 2,095,491 | 2.1 M to 2.1 M (-0.47 %) |
Dec 18 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Buy | P | 17.00 | 500,000 | 8,500,000 | 2,283,131 | 1.8 M to 2.3 M (+28.04 %) |
Nov 26 2014 | FLXN | Flexion Therapeuti ... | DRISCOLL FREDERICK W | Chief Financial Off ... | Buy | J | 11.91 | 1,443 | 17,186 | 1,443 | 0 to 1.4 K |
Nov 26 2014 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | J | 11.91 | 1,784 | 21,247 | 275,445 | 273.7 K to 275.4 K (+0.65 %) |
Sep 12 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | Director | Option Exercise | X | 17.61 | 2,250 | 39,623 | 6,750 |